中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600252 中恒集团

已收盘 12-12 15:00:00

{"stockData":{"symbol":"600252","market":"SH","secType":"STK","nameCN":"中恒集团","latestPrice":2.76,"timestamp":1765522800000,"preClose":2.77,"halted":0,"volume":62376830,"delay":0,"changeRate":-0.0036,"floatShares":3184000000,"shares":3195000000,"eps":-0.1138,"marketStatus":"已收盘","change":-0.01,"latestTime":"12-12 15:00:00","open":2.78,"high":2.79,"low":2.75,"amount":173000000,"amplitude":0.0144,"askPrice":2.76,"askSize":2981,"bidPrice":2.75,"bidSize":17590,"shortable":0,"etf":0,"ttmEps":-0.1138,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":2.77,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":3.05,"lowLimit":2.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3195228370,"isCdr":false,"pbRate":1.52,"roa":"--","roe":"0.4%","epsLYR":-0.1119,"committee":0.008771,"marketValue":8819000000,"turnoverRate":0.0196,"status":1,"floatMarketCap":8788000000},"requestUrl":"/m/hq/s/600252/tweets","defaultTab":"tweets","newsList":[{"id":"2590867205","title":"中恒集团最新公告：控股孙公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2590867205","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590867205?lang=zh_cn&edition=full","pubTime":"2025-12-10 19:03","pubTimestamp":1765364590,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称，公司控股子公司重庆莱美药业之子公司海南莱美医疗器械有限公司近日收到海南省药品监督管理局颁发的两项《医疗器械注册证》，分别是医用电子内窥镜图像处理器和电子支气管镜，有效期均为2025年11月17日至2030年11月16日。该产品能直接观察患者图像，有利于临床使用对患者病症的判断及治疗。此次产品获证将进一步丰富公司医疗器械产品种类，满足市场多样化的需求，提升公司综合竞争力，对未来经营将产生积极影响。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251210/31856961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["600252","BK0239","BK0012","09996","BK1100","159883","BK0028","BK0015","BK1574","BK0077","BK1222","BK0188","09997","BK1583"],"gpt_icon":0},{"id":"2588237880","title":"中恒集团（600252）披露控股孙公司获得药物临床试验批准通知书，12月04日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588237880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588237880?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:22","pubTimestamp":1764858145,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，中恒集团报收于2.98元，较前一交易日下跌1.0%，最新总市值为95.22亿元。近日，广西梧州中恒集团股份有限公司发布公告称，其控股孙公司四川瀛瑞医药科技有限公司自主研发的创新抗癌药物“纳米炭铁混悬注射液”获国家药品监督管理局批准，同意其联合标准放疗在实体瘤患者中开展临床试验。该药物为新一代纳米药物，通过调控铁死亡通路发挥抗癌作用，目前二期临床试验进展顺利，已累计投入研发费用9,428.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600252","BK0239","BK0077","BK0028","BK0015","BK0012"],"gpt_icon":0},{"id":"2588888323","title":"中恒集团最新公告：控股孙公司纳米炭铁混悬注射液药物临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2588888323","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588888323?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:59","pubTimestamp":1764842378,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称，近日，公司控股子公司重庆莱美药业股份有限公司之子公司四川瀛瑞医药科技有限公司自主研发的创新抗癌药物“纳米炭铁混悬注射液”获国家药监局签发《药物临床试验批准通知书》，同意该药品联合标准放疗在实体瘤患者中开展临床试验。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400028283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","600252","BK0239","BK0028","BK0077","BK0012","BK0188"],"gpt_icon":0},{"id":"2586286416","title":"异动快报：中恒集团（600252）11月26日9点49分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2586286416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586286416?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:50","pubTimestamp":1764121834,"startTime":"0","endTime":"0","summary":"证券之星11月26日盘中消息，9点49分中恒集团触及涨停板。其所属行业中药目前上涨。领涨股为粤万年青。该股为医药，中药，广西概念概念热股，当日医药概念上涨1.77%，中药概念上涨1.74%，广西概念概念上涨0.65%。11月25日的资金流向数据方面，主力资金净流入625.72万元，占总成交额5.58%，游资资金净流入472.78万元，占总成交额4.22%，散户资金净流出1098.5万元，占总成交额9.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600006640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600252","BK0077","BK0239","BK0015","BK0012","BK0028"],"gpt_icon":0},{"id":"2580142394","title":"中恒集团（600252）2025年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2580142394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580142394?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:06","pubTimestamp":1761948392,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期中恒集团发布2025年三季报。根据财报显示，中恒集团营收净利润同比双双增长。截至本报告期末，公司营业总收入19.48亿元，同比上升1.1%，归母净利润2464.04万元，同比上升119.61%。按单季度数据看，第三季度营业总收入4.97亿元，同比下降3.65%，第三季度归母净利润-243.72万元，同比上升77.2%。本次财报公布的各项数据指标表现一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100005313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"gpt_icon":0},{"id":"2579110363","title":"中恒集团最新公告：控股子公司莱美药业产品尼可地尔片拟中选第十一批全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2579110363","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579110363?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:02","pubTimestamp":1761822123,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称，公司控股子公司莱美药业参加了第十一批全国药品集中采购并拟中选尼可地尔片，该产品尚未开展销售。若后续签订采购合同并实施，将促进产品销售和市场拓展，提升公司品牌影响力，对长远发展有积极影响。但中标结果和采购合同签订存在不确定性，且药品生产和销售受多种因素影响，投资者需谨慎决策并注意投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600252","BK0015","BK0012","BK0028","BK0070","BK0188","300006","BK0239"],"gpt_icon":0},{"id":"2578792502","title":"每周股票复盘：中恒集团（600252）累计回购超2.91亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2578792502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578792502?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:28","pubTimestamp":1761420492,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，中恒集团报收于2.8元，较上周的2.78元上涨0.72%。本周，中恒集团10月22日盘中最高价报2.87元。10月20日盘中最低价报2.77元。中恒集团当前最新总市值89.47亿元，在中药板块市值排名28/67，在两市A股市值排名2060/5160。截至目前，公司已累计实施3次股份购，共购股份超2.91亿股，并已全部完成注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600252","BK0028","BK0077","BK0015","BK0012","BK0239"],"gpt_icon":0},{"id":"2577680801","title":"股市必读：中恒集团（600252）10月21日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2577680801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577680801?lang=zh_cn&edition=full","pubTime":"2025-10-22 01:26","pubTimestamp":1761067569,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，中恒集团报收于2.85元，上涨1.79%，换手率1.79%，成交量57.04万手，成交额1.61亿元。中恒集团围绕心脑血管及慢性病领域，2024年立项4个中药创新药和1个化药创新药，2025年积极引进化药1类新药“一种治疗慢性心力衰竭的药物”，开展3个中药3类新药经典名方的中试研究，推动中药1类新药“三芪颗粒”获得临床试验批准通知书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200000945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0015","BK0239","BK0077","BK0012","600252"],"gpt_icon":0},{"id":"2569245088","title":"每周股票复盘：中恒集团（600252）控股子公司获两项药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2569245088","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569245088?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:48","pubTimestamp":1758397695,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，中恒集团报收于2.83元，较上周的2.77元上涨2.17%。本周关注点公司公告汇总：控股子公司莱美药业获得尼可地尔片和酮咯酸氨丁三醇注射液药品注册证书。广西梧州中恒集团股份有限公司拟回购注销11,065,300股限制性股票，其中因2024年度业绩未达标涉及4名激励对象102,000股，因204名激励对象自愿退出及7名不再具备激励条件合计10,963,300股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600252","BK0239","BK0012","BK0188","BK0015","BK0028"],"gpt_icon":0},{"id":"2567357711","title":"每周股票复盘：中恒集团（600252）提名李骅为独董候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2567357711","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567357711?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:15","pubTimestamp":1757794514,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，中恒集团报收于2.77元，较上周的2.72元上涨1.84%。本周关注点公司公告汇总：中恒集团提名李骅为独立董事候选人，接替任职期满的李俊华。公司公告汇总广西梧州中恒集团股份有限公司于2025年9月12日召开第十届董事会第三十一次会议，审议通过提名李骅先生为公司第十届董事会独立董事候选人。该提名议案需提交股东大会审议，且候选人任职资格须经上海证券交易所审核无异议后，方可提交表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0015","BK0239","BK0077","BK0012","600252"],"gpt_icon":0},{"id":"2563837819","title":"每周股票复盘：中恒集团（600252）Q2净利增126.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563837819","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563837819?lang=zh_cn&edition=full","pubTime":"2025-08-31 15:37","pubTimestamp":1756625828,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，中恒集团报收于2.73元，较上周的2.88元下跌5.21%。股本股东变化截至2025年6月30日，中恒集团股东户数为11.49万户，较3月31日减少7,404户，减幅6.05%。业绩披露要点中恒集团2025年中报显示，主营收入14.51亿元，同比上升2.84%；归母净利润2,707.76万元，同比上升23.59%；扣非净利润2,483.02万元，同比上升196.24%。回购股份将于2025年8月27日注销，总股本由3,313,345,567股减少至3,195,228,370股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100005100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0012","600252","BK0077","BK0015","BK0028"],"gpt_icon":0},{"id":"2563021040","title":"中恒集团：2025年上半年净利润2707.76万元，同比增长23.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563021040","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563021040?lang=zh_cn&edition=full","pubTime":"2025-08-29 22:11","pubTimestamp":1756476689,"startTime":"0","endTime":"0","summary":"中恒集团公告，2025年上半年营业收入14.51亿元，同比增长2.84%。净利润2707.76万元，同比增长23.59%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/29221152819296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600252"],"gpt_icon":0},{"id":"2561410255","title":"每周股票复盘：中恒集团（600252）为子公司提供1000万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2561410255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561410255?lang=zh_cn&edition=full","pubTime":"2025-08-24 07:42","pubTimestamp":1755992535,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，中恒集团报收于2.88元，较上周的2.85元上涨1.05%。本周，中恒集团8月19日盘中最高价报2.91元。本周关注点公司公告汇总：中恒集团为重庆莱美隆宇药业有限公司提供1000万元的综合授信额度担保公司公告汇总中恒集团发布公告称，控股子公司重庆莱美药业股份有限公司为全资子公司重庆莱美隆宇药业有限公司向恒丰银行股份有限公司重庆分行申请的人民币1000万元综合授信额度提供连带责任保证担保，贷款期限一年。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400002205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","BK0028","BK0077","BK0239","600252","BK0015"],"gpt_icon":0},{"id":"2561019417","title":"中恒集团获融资买入0.12亿元，近三日累计买入0.50亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561019417","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561019417?lang=zh_cn&edition=full","pubTime":"2025-08-22 08:02","pubTimestamp":1755820965,"startTime":"0","endTime":"0","summary":"8月21日，沪深两融数据显示，中恒集团获融资买入额0.12亿元，居两市第1370位，当日融资偿还额0.18亿元，净卖出552.37万元。最近三个交易日，19日-21日，中恒集团分别获融资买入0.22亿元、0.16亿元、0.12亿元。融券方面，当日融券卖出0.35万股，净买入0.11万股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/22080252600354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","600252","BK0028","BK0077","BK0015","BK0012","BK0239"],"gpt_icon":0},{"id":"2559106670","title":"中恒集团：公司业务主要以国内为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2559106670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559106670?lang=zh_cn&edition=full","pubTime":"2025-08-13 16:21","pubTimestamp":1755073286,"startTime":"0","endTime":"0","summary":"证券之星消息，中恒集团(600252)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司2023年是否出口欧盟国家，感谢您的回复中恒集团回复：公司业务主要以国内为主，海外市场业务占整体业务的比例极小。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081300025637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0188","600252","BK0239","BK0077","BK0012","BK0028"],"gpt_icon":0},{"id":"2558711507","title":"每周股票复盘：中恒集团（600252）全资子公司5500万元受让心衰治疗药物技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2558711507","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558711507?lang=zh_cn&edition=full","pubTime":"2025-08-10 03:36","pubTimestamp":1754768177,"startTime":"0","endTime":"0","summary":"截至2025年8月8日收盘，中恒集团报收于2.82元，较上周的2.76元上涨2.17%。本周，中恒集团8月6日盘中最高价报3.23元。本周关注点公司公告汇总：中恒集团全资子公司以5500万元受让一种治疗慢性心力衰竭的药物技术公司公告汇总广西梧州中恒集团股份有限公司全资子公司广西中恒创新医药研究有限公司以5500万元受让中国融通科学研究院集团有限公司在上海技术交易所公开挂牌转让的一种治疗慢性心力衰竭的药物技术（专利权）。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000000639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600252","BK0188","BK0028","BK0015","BK0077","BK0239"],"gpt_icon":0},{"id":"2557732554","title":"个股概念调整|中恒集团新增“创新药”概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2557732554","media":"市场透视","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557732554?lang=zh_cn&edition=full","pubTime":"2025-08-06 15:15","pubTimestamp":1754464507,"startTime":"0","endTime":"0","summary":"2025年08月06日，中恒集团新增了创新药概念。中恒集团的所属概念，还有：昨日首板、昨日涨停、融资融券、白酒概念、医疗器械概念、参股券商、茯苓概念、金银花概念、三七概念、血塞（栓）通、转融券标的、标普道琼斯中国、中成药。个股概念调整既是市场认知的再校准，也是企业战略的显性化映射。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806151518a6d5fef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806151518a6d5fef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0015","BK0188","BK0239","BK0077","BK0012","159992","600252","BK0028"],"gpt_icon":0},{"id":"2557359461","title":"白酒概念盘中拉升，中恒集团等2只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2557359461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557359461?lang=zh_cn&edition=full","pubTime":"2025-08-05 11:14","pubTimestamp":1754363693,"startTime":"0","endTime":"0","summary":"08月05日，白酒概念盘中拉升，截至11点14分，白酒概念整体指数上涨1.00%，报3431.990点。从个股上来看，该概念的成分股中，中恒集团等2只股票涨停，*ST岩石、巨力索具、武商集团涨幅居前。从资金上来看，截止发稿，白酒概念概念主力净流入为2.20亿，其中山西汾酒受到资金热捧，主力净流入9007.42万；拉长时间线来看，该板块近20日主力资金净流入-68.67亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805111453a6d38fc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805111453a6d38fc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","SGXZ49509284.SGD","BK0175","BK0188","LU1997245177.USD","BK0012","600696","LU1781817850.SGD","600252","600809","LU1580142542.USD","LU1997245094.SGD","BK0077","BK0028","SGXZ81163826.USD","BK0215","BK0015"],"gpt_icon":0},{"id":"2557566853","title":"广西板块盘中拉升，中恒集团涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2557566853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557566853?lang=zh_cn&edition=full","pubTime":"2025-08-05 10:05","pubTimestamp":1754359514,"startTime":"0","endTime":"0","summary":"08月05日，广西板块盘中拉升，截至10点05分，广西板块整体指数上涨1.01%，报1934.960点。从个股上来看，该板块的成分股中，中恒集团涨停，ST八菱、东方智造、*ST阳光涨幅居前。从资金上来看，截止发稿，广西板块主力净流入为8671.69万，其中中恒集团受到资金热捧，主力净流入6915.63万；拉长时间线来看，该板块近20日主力资金净流入-30.05亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805100514a6d36f62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805100514a6d36f62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0015","BK0012","BK0188","BK0028","BK0077","600252","BK0239"],"gpt_icon":0},{"id":"2557551513","title":"化债(AMC)概念盘中拉升，中恒集团涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2557551513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557551513?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:54","pubTimestamp":1754358854,"startTime":"0","endTime":"0","summary":"08月05日，化债(AMC)概念盘中拉升，截至09点54分，化债(AMC)概念整体指数上涨1.00%，报1224.060点。从个股上来看，该概念的成分股中，中恒集团涨停，中源协和、东兴证券、上海建科涨幅居前。从资金上来看，截止发稿，化债(AMC)概念主力净流入为6983.66万，其中中恒集团受到资金热捧，主力净流入6475.05万；拉长时间线来看，该板块近20日主力资金净流入-66.77亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805095414a6d36987&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805095414a6d36987&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600252","BK0028","BK0077","BK0015","BK0012","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765738227485,"stockEarnings":[{"period":"1week","weight":-0.08},{"period":"1month","weight":-0.0417},{"period":"3month","weight":-0.0036},{"period":"6month","weight":0.0656},{"period":"1year","weight":-0.0612},{"period":"ytd","weight":0.122}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广西梧州中恒集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"118959人(较上一季度增加3.54%)","perCapita":"26766股","listingDate":"2000-11-30","address":"广西壮族自治区梧州市万秀区工业园区工业大道1号第1幢","registeredCapital":"319522万元","survey":"　　广西梧州中恒集团股份有限公司的主营业务是医药制造。公司的主要产品是心脑血管领域用药、骨骼肌肉领域用药、其他普药系列、特色专科类、大输液类、抗感染类、其他品种、药品销售服务、医药流通类、龟苓膏系列、龟苓宝系列、其他食品系列。中恒集团为国家高新技术企业，国家高新技术创新示范企业、国家知识产权示范企业，国家第二批先进制造业和现代服务业融合发展试点企业，位居中国医药工业百强、中华民族医药百强，具备领域优势和产品优势。","listedPrice":5.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中恒集团,600252,中恒集团股票,中恒集团股票老虎,中恒集团股票老虎国际,中恒集团行情,中恒集团股票行情,中恒集团股价,中恒集团股市,中恒集团股票价格,中恒集团股票交易,中恒集团股票购买,中恒集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}